Comerica Bank’s Vaxcyte PCVX Stock Holding History

Comerica Bank’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$50.9K	Sell	1,103 -653,266	-100%	-$29.2M	﹤0.01%	2847
2025 Q3	$23.6M	Buy	654,369 +174,859	+36%	+$5.79M	0.09%	215
2025 Q2	$15.6M	Buy	479,510 +119,324	+33%	+$3.91M	0.06%	315
2025 Q1	$13.6M	Buy	360,186 +21,091	+6%	+$1.69M	0.06%	322
2024 Q4	$27.8M	Buy	339,095 +66,073	+24%	+$6.56M	0.11%	166
2024 Q3	$31.2M	Sell	273,022 -3	-0%	-$270	0.12%	154
2024 Q2	$20.6M	Buy	273,025 +84,941	+45%	+$5.78M	0.09%	219
2024 Q1	$12.8M	Buy	188,084 +246	+0.1%	+$17K	0.06%	343
2023 Q4	$11.8M	Buy	187,838 +101,407	+117%	+$5.27M	0.05%	346
2023 Q3	$4.41M	Buy	+86,431	New	+$4.26M	0.02%	681

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Comerica Bank's PCVX Position: Q4 2025 in Review

Comerica Bank reduced its Vaxcyte (PCVX) stake by 100% in Q4 2025, selling an estimated $29.2M and leaving 1,103 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2847.

Comerica Bank first reported a position in PCVX in Q3 2023 and has held it in 10 quarters since. The position peaked at $31.2M in Q3 2024. 295 funds tracked by Wall St. Rank hold PCVX as of Q4 2025.

Comerica Bank held 1,103 shares of Vaxcyte worth $50.9K as of Q4 2025.
Comerica Bank sold 653,266 Vaxcyte shares in Q4 2025, an estimated $29.2M.
Vaxcyte made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2847 holding.
Comerica Bank first reported a position in Vaxcyte in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Vaxcyte position peaked at $31.2M in Q3 2024.
295 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.